HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
January 14, 2025
Host Jonathan Miller interviews CEO: Ram Mukunda, who shows us how the company is pushing the boundaries of scientific discovery, creating life-changing medications, and improving the quality of life for individuals around the globe.
January 14, 2025
July 16, 2024
July 9, 2024
June 27, 2024